杨玉社, 嵇汝运, 陈凯先, 叶辉, 武济民. 抗支原体喹诺酮的合成及其构效关系J. 药学学报, 1999, 34(5): 349-352.
引用本文: 杨玉社, 嵇汝运, 陈凯先, 叶辉, 武济民. 抗支原体喹诺酮的合成及其构效关系J. 药学学报, 1999, 34(5): 349-352.
Yang Yushe, Ji Ruyun, Chen Kaixian, Ye Hui , Wu Jimin, . STUDIES ON SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTIMYCOPLASMA QUINOLONESJ. Acta Pharmaceutica Sinica, 1999, 34(5): 349-352.
Citation: Yang Yushe, Ji Ruyun, Chen Kaixian, Ye Hui , Wu Jimin, . STUDIES ON SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTIMYCOPLASMA QUINOLONESJ. Acta Pharmaceutica Sinica, 1999, 34(5): 349-352.

抗支原体喹诺酮的合成及其构效关系

STUDIES ON SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTIMYCOPLASMA QUINOLONES

  • 摘要: 目的:开发新型抗支原体药物。方法与结果:设计合成了一系列新型左旋氧氟沙星类似物(18~24),测试其体外抗支原体活性(MIC值),并讨论了他们的构效关系。结论:所合成的化合物有较好的抗支原体活性。哌嗪环或高哌嗪环4位氮原子有吸电子基团时,可能有利于提高喹诺酮的抗支原体活性。

     

    Abstract: AIM: To develop new antimycoplasma drugs. METHODS and RESULTS: A series of new analogues of (S)-(-)-ofloxacin with antimycoplasma activities were prepared. Compounds 18~24 were new compounds. Their in vitro susceptibilities to mycoplama were tested. The influences on structure-activity relationships were also discussed. CONCLUSION: The synthesized compounds have good activities against mycoplasma. The electron-withdrawing groups on the 4-position of piperazine or homopiperazine may be favorable for antimycoplasma activity.

     

/

返回文章
返回